NSGNursing Study Group

NCLEX-style practice question

A nurse is caring for a client who takes a medication that must cross the blood-brain barrier to treat Parkinson's disease. Which statement best explains how the combination product achieves this?

  1. The carbidopa component carries levodopa across the blood-brain barrier, where it is converted to dopamine.
  2. The carbidopa component blocks dopamine receptors so that levodopa can enter neurons directly.
  3. The levodopa component is lipid-soluble and crosses the barrier unchanged before being converted to carbidopa.
  4. The levodopa component dissolves the blood-brain barrier so that carbidopa can enter the brain.
Show answer and rationale

Correct answer: A. The carbidopa component carries levodopa across the blood-brain barrier, where it is converted to dopamine.

Carbidopa is designed to act as a carrier that moves levodopa across the blood-brain barrier, where levodopa is converted to dopamine. The distractor about carbidopa blocking receptors describes a different mechanism and does not address how the drug reaches the brain.

Adapted from Open RN Nursing Pharmacology, Chippewa Valley Technical College, CC BY 4.0.

Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies

Practice every question freeFree account: the full question bank, NCLEX-RN and PN practice exams, flashcards, an AI study tutor and a study group forum.
Create a free account

More Pharmacological and Parenteral Therapies / Pharmacological Therapies questions

See all 440 →

Practice questions are study aids written with AI from openly licensed nursing textbooks and can contain mistakes. They are not NCLEX questions and are not endorsed by NCSBN.